Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 3 to 7, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 3 to 7, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Many Oncology Patients Are Lonely During COVID-19
FRIDAY, May 7, 2021 (HealthDay News) — More than half of oncology patients are experiencing loneliness during the COVID-19 pandemic, and they report higher symptom severity scores for all symptoms evaluated, according to a study published online April 27 in Cancer.
Poll Finds Many Parents Hesitant to Get Younger Children Vaccinated
FRIDAY, May 7, 2021 (HealthDay News) — As U.S. health officials prepare to authorize the Pfizer COVID-19 vaccine for emergency use in younger children, a new poll shows that less than a third of parents would get their child vaccinated as soon as the shots are approved.
U.S. Likely to Achieve July 4 COVID-19 Vaccination Target, but Challenges Remain
FRIDAY, May 7, 2021 (HealthDay News) — It is likely that the United States will achieve President Joe Biden’s target of having at least one dose of a COVID-19 vaccine into the arms of 70 percent of adults by July 4, but there could be challenges later in the year.
Response to COVID-19 Vaccine Positive in Patients With IBD
FRIDAY, May 7, 2021 (HealthDay News) — Inflammatory bowel disease patients taking biologics achieved a positive antibody response to both the Moderna and Pfizer COVID-19 vaccines, according to research published online April 19 in Gastroenterology.
Vaccination, NPI Compliance Needed to Prevent COVID-19 Surges
THURSDAY, May 6, 2021 (HealthDay News) — To prevent surges in COVID-19 cases, hospitalizations, and deaths, high vaccination rates and compliance with nonpharmaceutical interventions are needed, according to research published in the May 5 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Two Doses of BNT162b2 SARS-CoV-2 Vaccine Highly Effective
THURSDAY, May 6, 2021 (HealthDay News) — Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 infections and other outcomes, according to a study published online May 5 in The Lancet.
Pfizer to Seek Approval in Fall for COVID-19 Vaccine Use in Children Aged 2 to 11
THURSDAY, May 6, 2021 (HealthDay News) — Emergency use authorization for the Pfizer COVID-19 vaccine to be given to children ages 2 to 11 years could be sought from the U.S. Food and Drug Administration by September, the company said Tuesday.
Biden Administration to Back Lifting of COVID-19 Vaccine Patents
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
